Germany· DE-A57-f18ffd247a728220
Indometacin Al
A indometacin product containing indometacin, registered in Germany by Aliud Pharma Gmbh. The same ATC class is registered in 10 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Indometacin is registered in 10 of 19 countries.
Countries holding a registration under ATC M01AB01 (indometacin), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 6 of them publish a price we can compare per daily dose
Indometacin · ATC M01AB01
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of indometacin costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Indometacin · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.16
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Indometacin
- Manufacturer
- Aliud Pharma Gmbh
- Country
- Germany (DE)
- ATC code
- M01AB01
- ATC class
- Indometacin
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
398 interactions on record for indometacin.
Graded by severity as the source publishes them — 57 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Indometacin · interactions on record
398 records
- 57 severe
- 157 moderate
- 15 minor
- 97 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
72 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Indometacin in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBerlind 75 Retard capsulesTillomed Laboratories Ltd
- United StatesIndocinZyla Life Sciences US LLC
- NorwayIndocidHAC Pharma
- FinlandConfortidAlpharma ApS
- SpainALIVIOSIN 100 mg SUPOSITORIOSEspecialidades Farmaceuticas Centrum S.A.
- PolandElmetacinInPharm Sp. z o.o.
- CanadaAURO-INDOMETHACINAURO PHARMA INC
- BelgiumDolcidium 100 mgLaboratoires S.M.B.
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Indocid, Mobiflex
- Belgium · Indocollyre, Sportflex
- Bulgaria · Индометацин Дс, Индометацин Софарма
- Cyprus · Indorem, Indylon
- Czechia · Elmetacin, Indocollyre
- Spain · Aliviosin, Artrinovo
- France · Chrono-Indocid, Indocid
- United Kingdom (Northern Ireland) · Berlind Retard, Indolar Sr
- Greece · Fortathrin, Reumadolor
- Croatia · Indometacin Belupo
- Hungary · Indocollyre
- Italy · Indocollirio, Indom
- Lithuania · Metindol
- Luxembourg · Indocollyre, Sportflex
- Latvia · Indometacin Sopharma, Metindol
- Netherlands · Indometacine Aurobindo, Indometacine Cf
- Poland · Elmetacin, Metindol Retard
- Portugal · Autritis, Elmetacin
- Romania · Indocollyre, Indometacin Arena
- Slovakia · Elmetacin, Indometacin Berlin-Chemie
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/409f4141-7b04-45de-b0d7-55496f0cfc87 GET /v1/drugs/409f4141-7b04-45de-b0d7-55496f0cfc87?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Indometacin",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about indometacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.